Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
RESEARCH TRIANGLE PARK, N.C., May 20 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lawrence D. Stern, chairman and chief executive officer of Talecris, will present at the 2010 Citi Investment Research Global Health Care Conference at 11:30 a.m., Thursday, May 27, 2010, at the Hilton New York Hotel in New York, N.Y.
A live webcast of Talecris' presentation will be accessible through the investor relations section of the Talecris Web site, www.talecris.com/investor-relations.htm. A replay of the webcast will be available until June 10, 2010, and can be accessed at the same Web address.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.
SOURCE Talecris Biotherapeutics, Inc.